Results 131 to 140 of about 7,096 (184)

Comparison of inebilizumab or rituximab in addition to glucocorticoid therapy for neuromyelitis optica spectrum disorders. [PDF]

Int J Ophthalmol
Lou CY, Wang Y, Xing JY, Ma T, Tao L, Wang XT, Wang RS.   +6 more
europepmc   +1 more source

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort. [PDF]

Eur J Neurol
Samadzadeh S, Oertel FC, Salih H, Lin TY, Motamedi S, Chien C, Cook LJ, Lana-Peixoto MA, Fontenelle MA, Kim HJ, Hyun JW, Jung SK, Palace J, Roca-Fernandez A, Leite MI, Sharma SM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, Dcunha A, Aktas O, Ringelstein M, Albrecht P, May EF, Tongco C, Leocani L, Pisa M, Radaelli M, Sánchez-Dalmau B, Martinez-Lapiscina EH, Stiebel-Kalish H, Hellmann MA, Lotan I, Siritho S, de Seze J, Senger T, Havla J, Marignier R, Tilikete CF, Cobo-Calvo A, Bichuetti D, Tavares IM, Soelberg K, Altintas A, Yildirim R, Tanriverdi U, Jacob A, Huda S, Rimler Z, Reid A, Mao-Draayer Y, Villoslada P, de Castillo IS, Green A, Petzold A, Yeaman MR, Smith TJ, Brandt AU, Zimmermann HG, Paul F, Asgari N, Guthy Jackson Charitable Foundation – International Clinical Consortium and CROCTINO Collaborators.   +63 more
europepmc   +1 more source

Nocardia farcinica pneumonia complicated by pneumocystis jiroveci infection in children with Neuromyelitis Optica Spectrum Disorders: a case report and literature review. [PDF]

Ital J Pediatr
Liu L, Huang Y, Shu S, Zhou H, Fang F, Liu X.   +5 more
europepmc   +1 more source

Neuromyelitis optica spectrum disorder

, 2012
openaire   +1 more source

Comparison of treatment efficacy and cost-effectiveness of rituximab and oral agents among patients with neuromyelitis optica spectrum disorders: a population-based cohort study. [PDF]

Ther Adv Neurol Disord
Lee HL, Kang M, Seok JM, Kim BJ, Kim BJ.
europepmc   +1 more source

Association Between Serum Interleukin-32 Level and Disease Status in Cases with Neuromyelitis Optica Spectrum Disorders. [PDF]

J Inflamm Res
Yu HF, Xu J, Fang Y, Xiao LC.
europepmc   +1 more source

Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients. [PDF]

Sci Rep
Taha SI, Bakr SI, Fouad NT, Zamzam D, Mohamed YA.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neuromyelitis optica spectrum disorders in Iran

Multiple Sclerosis and Related Disorders, 2017
Neuromyelitys optica spectrum disorder (NMOSD) is a rare demyelinating disease; as a result, the epidemiological data on this disorder is scarce. In this regard, the aim of this study was to estimate the prevalence, serology, and clinical features of NMOSD in Caucasian population in Tehran, Iran.A cross sectional study was performed in Tehran from 2015
Sharareh Eskandarieh, Saharnaz Nedjat, Amirreza Azimi   +2 more
exaly   +3 more sources